A detailed history of Fieldpoint Private Securities, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 35 shares of FLGT stock, worth $644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 120 70.83%
Holding current value
$644
Previous $7,000 71.43%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$47.98 - $62.75 $4,078 - $5,333
-85 Reduced 70.83%
35 $2,000
Q1 2022

Apr 07, 2022

BUY
$49.85 - $96.11 $4,486 - $8,649
90 Added 300.0%
120 $7,000
Q4 2021

Jan 24, 2022

SELL
$77.3 - $105.0 $1,546 - $2,100
-20 Reduced 40.0%
30 $3,000
Q3 2021

Nov 12, 2021

SELL
$74.87 - $110.87 $1,123 - $1,663
-15 Reduced 23.08%
50 $4,000
Q2 2021

Aug 12, 2021

BUY
$66.8 - $100.45 $3,340 - $5,022
50 Added 333.33%
65 $6,000
Q1 2021

Apr 23, 2021

BUY
$59.3 - $183.85 $889 - $2,757
15 New
15 $1,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $557M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.